NL-OMON25859招募中不适用
Effects of Tocilizumab (RoACTEMRA®) on Biomarkers in Synovial Tissue of Patients with Rheumatoid Arthritis.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- AMC
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Males/females suffering from RA, classified according to the 2010 ACR/EULAR classification criteria for RA, who have active disease (DAS28 „d3.2) despite adequate methorexate treatment, will be eligible for the study. Patients in ARA functional classes I, II, and III may be included.
- •In addition, patients must fulfill the following criteria at baseline:
排除标准
- •1. Pregnancy;
- •2. Breastfeeding;
研究者
相似试验
撤回
4 期
Effects of Tocilizumab (RoACTEMRA) on biomarkers in synovial tissue of patients with rheumatoid arthritisRheumatiod Arthritis10003816NL-OMON36162Academisch Medisch Centrum20
招募中
3 期
Evaluation of The effect of tocilizumab on patients with severe Covid 19IRCT20210408050899N1Ahvaz University of Medical Sciences15
Unknown
不适用
The Safety and Effectiveness of Tocilizumab in Rheumatoid ArthritisArthritis, RheumatoidNCT04384068Peking Union Medical College Hospital2,500
已完成
不适用
An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)Rheumatoid ArthritisNCT01394276Hoffmann-La Roche322
Unknown
4 期
Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid ArthritisTocilizumabRheumatoid ArthritisNCT03781310Tel-Aviv Sourasky Medical Center80